Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated informed consent~* Male or female aged from 40 to 88 years old~* Scheduled to undergo unilateral cataract surgery~Exclusion criteria:~* Combined surgery~* Previous intraocular surgery

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 88 Years
- Healthy Volunteers: f

Study Arms:
- T2380 (Type: EXPERIMENTAL): Topical anaesthetic: Tetracaine was instilled in the eye to be operated before surgery.~At the beginning of surgery, 200 μL of T2380 were administrated intracamerally.
- Mydriatics and anesthetic (Type: ACTIVE_COMPARATOR): Topical anaesthetic: Tetracaine was instilled in the eye to be operated before surgery.~Topical Mydriatic treatments were instilled three times before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).